Morag Park is a professor in the Departments of Oncology and Biochemistry at McGill University. She is a Knight of the Ordre national du Québec, a Fellow of the Royal Society of Canada, a Fellow of the Canadian Academy of Health Sciences, and a James McGill Distinguished Professor, and holds the Diane and Sal Guerrera Chair in Cancer Genetics. She received a B.Sc. with first-class honors from the University of Glasgow and a Ph.D. at the Medical Research Council Virology Institute in Scotland and completed postdoctoral training at the National Institutes for Cancer Research in Washington, DC, US. She was the Director of the Molecular Oncology Group at the McGill University Health Centre (2006–2008), Scientific Director of the Institute of Cancer Research for the CIHR (2008–2013), and co-chair of the Canadian Cancer Research Alliance (2008–2010), and is now Director of the Goodman Cancer Institute (2013–present). She is a recipient of a Canadian Cancer Research Alliance Award (2015) for Exceptional Leadership in Cancer Research. She was a recipient of the Canadian Cancer Society Robert L. Noble Prize (2017), the Quebec Breast Cancer Foundation Grand Prix Scientifique (2019), and the Club de Recherches Cliniques du Québec Michel Sarrazin Award (2021).
Morag Park is a professor in the Departments of Oncology and Biochemistry at McGill University. She is a Knight of the Ordre national du Québec, a Fellow of the Royal Society of Canada, a Fellow of the Canadian Academy of Health Sciences, and a James McGill Distinguished Professor, and holds the Diane and Sal Guerrera Chair in Cancer Genetics. She received a B.Sc. with first-class honors from the University of Glasgow and a Ph.D. at the Medical Research Council Virology Institute in Scotland and completed postdoctoral training at the National Institutes for Cancer Research in Washington, DC, US. She was the Director of the Molecular Oncology Group at the McGill University Health Centre (2006–2008), Scientific Director of the Institute of Cancer Research for the CIHR (2008–2013), and co-chair of the Canadian Cancer Research Alliance (2008–2010), and is now Director of the Goodman Cancer Institute (2013–present). She is a recipient of a Canadian Cancer Research Alliance Award (2015) for Exceptional Leadership in Cancer Research. She was a recipient of the Canadian Cancer Society Robert L. Noble Prize (2017), the Quebec Breast Cancer Foundation Grand Prix Scientifique (2019), and the Club de Recherches Cliniques du Québec Michel Sarrazin Award (2021).